<DOC>
	<DOC>NCT01929291</DOC>
	<brief_summary>The purpose of this study is to collect safety information from pre-adolescents, adolescents and adults after Boostrix vaccination is administered according to the approved prescribing information in Korea.</brief_summary>
	<brief_title>Post-marketing Surveillance to Assess the Safety of Boostrix Vaccine Given According to Prescribing Information in Korea</brief_title>
	<detailed_description>Protocol amendment 3 rationale was as follows: - Age for analysis set is specified. - Subjects with pregnancy will be analyzed by their pregnancy status before/after vaccination. - Pregnancy notifications must be done within 2 weeks</detailed_description>
	<mesh_term>Whooping Cough</mesh_term>
	<mesh_term>Tetanus</mesh_term>
	<mesh_term>Diphtheria</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Written or signed informed consent obtained from the subject/ subject's parent(s)/Legally Acceptable Representative(s) of the child. Korean male or female subjects who were recently vaccinated or eligible to receive Boostrix according to the locally approved Prescribing Information. Those who are not eligible for vaccination according to the local Prescribing Information. Child in care.</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Korea</keyword>
	<keyword>Post-marketing surveillance</keyword>
	<keyword>Boostrix</keyword>
	<keyword>Prescribing information</keyword>
	<keyword>Safety</keyword>
</DOC>